Cargando…
Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Atlantis Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432347/ https://www.ncbi.nlm.nih.gov/pubmed/34595448 http://dx.doi.org/10.2991/chi.d.200507.001 |
| _version_ | 1783751140762976256 |
|---|---|
| author | Mohty, Mohamad Malard, Florent Bazarbachi, Ali |
| author_facet | Mohty, Mohamad Malard, Florent Bazarbachi, Ali |
| author_sort | Mohty, Mohamad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8432347 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Atlantis Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84323472021-09-29 Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better Mohty, Mohamad Malard, Florent Bazarbachi, Ali Clin Hematol Int Correspondence Atlantis Press 2020-05-18 /pmc/articles/PMC8432347/ /pubmed/34595448 http://dx.doi.org/10.2991/chi.d.200507.001 Text en © 2020 International Academy for Clinical Hematology. Publishing services by Atlantis Press International B.V. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ). |
| spellingShingle | Correspondence Mohty, Mohamad Malard, Florent Bazarbachi, Ali Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_full | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_fullStr | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_full_unstemmed | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_short | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_sort | bortezomib, lenalidomide and dexamethasone as induction therapy prior to autologous transplantation in multiple myeloma: the more is likely the better |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432347/ https://www.ncbi.nlm.nih.gov/pubmed/34595448 http://dx.doi.org/10.2991/chi.d.200507.001 |
| work_keys_str_mv | AT mohtymohamad bortezomiblenalidomideanddexamethasoneasinductiontherapypriortoautologoustransplantationinmultiplemyelomathemoreislikelythebetter AT malardflorent bortezomiblenalidomideanddexamethasoneasinductiontherapypriortoautologoustransplantationinmultiplemyelomathemoreislikelythebetter AT bazarbachiali bortezomiblenalidomideanddexamethasoneasinductiontherapypriortoautologoustransplantationinmultiplemyelomathemoreislikelythebetter |